Clotting Conditions Flashcards

1
Q

Clotting occurs in several steps:

A
  1. Vasoconstriction ← smooth muscle contraction
  2. Formation of platelet plug
  3. Clot reinforced by coagulation cascade→ Fibrin crosslinking
  4. Ends with fibrinolysis and restoration of blood flow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When a vessel is damaged- _____ is
exposed

A

collagen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Von Willebrand factor (vWF)

A

Forms a bridge between collagen of a damaged vessel and GPIb which is expressed on the surface of the platelet→ adhesion to the site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Platelet granules secret:

A

○ Adenosine diphosphate (ADP) released→ Activates nearby platelets
○ Arachidonic acid released which is converted to thromboxane A2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Eventually Factor X is activated by combination
of _____

A

IX and VIII and phospholipids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Measured with PT

A

Extrinsic pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Measured with aPTT

A

Intrinsic pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Intrinsic pathway is activated by ____

A

Activated by exposure to
collagen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Extrinsic pathway is activated by

A

Activated by presence of
tissue factor (III)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ultimately both pathways lead
to activation of Factor ___

A

X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Factors that Inhibit Coagulation

A

○ Protein C
○ Protein S
○ Antithrombin III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Protein C and S are ____ dependent proteins

A

Vit K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

_____ is a plasma protein which binds to
thrombin forming inert compound

A

Antithrombin III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Heparin acts to augment
____

A

Antithrombin III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Thrombophilia?

A

A condition where the blood has an increased tendency to form clots, potentially leading to life-threatening circumstances.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

____ is a major cause of morbidity and mortality throughout the world

A

Thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

_____ activates plasminogen into plasmin

A

tPA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

The 19th century pathologist Rudolf Virchow proposed three independent processes which could increase the risk of abnormal thrombosis

A

○ Abnormal Flow / Stasis
○ Vessel Wall Injury
○ Hypercoagulability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Inherited Disorders of hypercoagulable state

A

○ Factor V Leiden Mutation
○ Prothrombin G20210A Mutation
○ Protein S Deficiency
○ Protein C Deficiency
○ Antithrombin III Deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Acquired conditions of hypercoagulable states

A

○ Pregnancy-Related Hypercoagulability
○ Malignancy-Related Hypercoagulability
○ Antiphospholipid Antibody Syndrome
○ Heparin-Induced Thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Factor V plays a crucial role in the conversion of Prothrombin to Thrombin and is normally inactivated by ____

A

Protein C (and S).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Factor V Leiden is ____ 10 times slower than
normal Factor V.

A

inactivated by Protein C
○ Leads to increased coagulation - more
Thrombin is created.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Factor V Leiden

A

Mutation of Factor V

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

____ is by far the most common
inherited risk factor for thrombophilia

A

Factor V Leiden mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
The _____ triggers an overproduction of the Prothrombin protein (Factor II).
Prothrombin G20210A genetic mutation
26
Normally, Protein C works to ____
inactivate Factors VIII and V in an effort to slow down or inhibit coagulation (anticoagulant).
27
Antithrombin III normally inactivates several coagulation factors, most importantly _____
Thrombin
28
_____ are at an increased risk of thrombosis (DVT and PE)
Pregnant women
29
Antiphospholipid Syndrome
Antiphospholipid Antibody Syndrome is a condition in which the body forms antibodies against proteins bound to the phospholipids necessary for the coagulation cascade.
30
Antiphospholipid Syndrome includes:
○ Lupus Anticoagulant ○ Anticardiolipin Antibody
31
What is lupus anticoagulant
Those with Lupus Anticoagulant are at increased risk of venous thrombosis and recurrent miscarriage.
32
Anticardiolipin Antibody
Those with Anticardiolipin Antibody are at increased risk of arterial thrombosis, concerning for myocardial infarction and peripheral arterial occlusions.
33
Heparin-Induced TCP (HIT)
an adverse reaction to the medication that occurs in 3% of those on unfractionated Heparin and 0.6% of those on LMWH.
34
HIT results from
formation of antibodies to the Heparin-Platelet Factor 4 (PF4) complex.
35
HIT usually occurs ____
5-10 days after initiation of Heparin.
36
A decline in baseline platelet count of 50% or more is diagnostic for
HIT
37
Treatment for HIT
○ Discontinue all forms of Heparin immediately. ○ Begin treatment with Direct Thrombin inhibitor (ie. Argatroban) or Direct Factor Xa Inhibitor (ie. Rivaroxaban). ○ Check US Doppler of LEs and monitor Platelet count. ○ When platelet # recovers, can transition to Warfarin for at least 30 days
38
Deep Vein Thrombosis S/S
○ Most commonly, patients present with… ■ Unilateral leg pain ■ Unilateral calf tenderness ■ Unilateral leg/ankle swelling
39
DVT diagnostic testing
○ The use of a Clinical Prediction Tool is suggested. ■ Wells Score System for DVT ○ If low probability based on Prediction Tool: ■ Order High-Sensitivity D-Dimer (blood test) ● Negative D-Dimer rules out DVT ○ If moderate probability of DVT: ■ High-Sensitivity D-Dimer or Compression Ultrasound ○ If high probability of DVT: ■ Compression Ultrasound is diagnostic test of choice
40
High-sensitive D-Dimer is very sensitive for ____
VTE
41
The presence of D-Dimer indicates that clotting _____
has occurred
42
Treatment and Management of DVT
○ Prevention in high-risk patients is critical! ○ Once diagnosed, Systemic Anticoagulation is treatment.
43
Inpatient treatment for DVT recommended if…
● Massive DVT ● Symptomatic Pulmonary Embolism ● High risk of bleeding with anticoagulation ● Significant comorbid conditions
44
Acute DVT treatment
○ Anticoagulation started immediately ○ Oral anticoagulant preferred for maintenance treatment ○ Anticoagulation is continued for at least 3 months.
45
In the treatment of acute DVT, Recent studies have shown that____
early ambulation is safe and recommended over bedrest
46
If there is a high degree of concern for a PE, an _____ can be placed endovascularly.
Inferior Vena Cava (IVC) Filter
47
_____ is the most significant complication of DVT.
Pulmonary Embolism
48
Pulmonary Embolism
● If a DVT breaks loose, it can travel through the heart and into the lungs.
49
Characteristic Signs and Symptoms of Pulmonary embolism
○ Sudden onset dyspnea ○ Tachypnea ○ Tachycardia ○ Pleuritic Chest Pain ○ Cough ○ Sometimes a fever ○ Symptoms of shock (massive PE) ○ Hemoptysis (not common) ○ Signs and symptoms of DVT are common
50
Diagnostic testing for pulmonary embolism
○ Pulmonary Embolism Rule-out Criteria (PERC) ○ The use of a Clinical Prediction Tool is suggested. ○ Low probability, D-Dimer is used to rule out PE ● If positive advance to CT Angio ○ Moderate probability, D-Dimer or below imaging. ○ High probability of PE, D-Dimer is not indicated.
51
Test of choice for pulmonary embolism
CT Pulmonary Angiography is test of choice
52
Treatment for PE If patient is hemodynamically stable
■ SC LMWH (Lovenox) is preferred over IV UFH. ■ More common- DOACs-Rivaroxaban or Apixaban.
53
Treatment for PE If massive PE with concern for shock
■ IV unfractionated Heparin is preferred. ■ IV Alteplase (a fibrinolytic called tPA) can also be used. ■ Endovascular pulmonary embolectomy is used as a measure of last resort ○ Long-term (at least 3-6 months) anticoagulation with an oral agent is recommended (Warfarin or NOAC ie. Novel oral anticoagulant)
54
____ occurs when platelet aggregation and the coagulation cascade are triggered by disease of the artery
Arterial thrombosis
55
Characteristic Presentation of arterial thrombosis
■ Myocardial Infarction ■ Unstable Angina ■ Ischemic Stroke ■ Acute Limb Ischemia of Peripheral Arterial Disease
56
Risk factors of arterial thrombosis
smoking, obesity, diabetes, hypertension, dyslipidemia, advancing age, atherosclerosis, and positive family history.
57
Treatment of Arterial thrombosis
○ Treatment specific to acute arterial thrombosis will be discussed in the above listed courses. ■ Mostly uses antiplatelet drugs ○ Prevention of atherosclerosis (by addressing modifiable risk factors) is critical to prevention of arterial thrombosis.
58
Virchow’s Triad
○ Venous Stasis ○ Vessel Wall Injury ○ Hypercoagulability
59
Patient with a DVT are at very high risk of ____
that clot breaking loose and traveling to the lungs, causing a Pulmonary Embolism.
60
Prevention of _____ is critical to prevention of arterial thrombosis.
atherosclerosis (by addressing modifiable risk factors)